# 119-s-5297: American Pharmaceutical Security Act

119-s-5297, American Pharmaceutical Security Act, is a 119th Congress bill sponsored by Sen. Schiff, Adam B. [D-CA] (D-CA); status introduced; PRIA reads it as touching household money (as of 2026-08-21).

- Canonical: https://policyrisk.com/legislation/119-s-5297
- As of: 2026-08-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-5297
- Congress: 119
- Title: American Pharmaceutical Security Act
- Status: introduced
- Introduced: 2026-08-06
- Sponsor: Sen. Schiff, Adam B. [D-CA] (D-CA)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-08-21

## Summary

**Use CMS coverage and reimbursement to protect U.S. drug ingredient supply and reduce reliance on foreign adversaries.** This bill would require the Centers for Medicare & Medicaid Services to deliver a report to Congress within one year evaluating how CMS tools could support domestic production of active pharmaceutical ingredients and key starting materials and to identify information gaps. - Congress and federal agencies: Receive a report with policy options, including recommendations for price floor commitments and prioritizing domestically manufactured APIs and starting materials when a domestic source exists. - Domestic manufacturers: The report may recommend steps to protect U.S. API and starting material makers from nonmarket pricing and to encourage investment in domestic production. - CMS and regulators: Must identify data and information gaps about the origin and ownership of APIs and key starting materials needed to implement any recommendations. - Patients and providers: The analysis is intended to inform future actions that could reduce supply vulnerabilities for medicines by shaping coverage and reimbursement policy.

## Cosponsors (1)

- Sen. Scott, Rick [R-FL] (R-FL), 2026-08-06T00:00:00.000Z

## Provisions PRIA read

- CMS study on drug ingredient supply: mixed, low. This bill would require the CMS Administrator to send Congress a report within one year. The report would analyze how CMS coverage and payment rules could protect U.S. and allied markets for active pharmaceutical ingredients and key starting materials and reduce dependence on foreign adversaries un…

## Related bills

- 119-s-4949: Water Resources Development Act of 2026
- 119-s-1541: SHIPS for America Act of 2025
- 119-s-2838: Protecting Our Democracy Act
- 119-s-2819: Head Start for America's Children Act
- 119-s-1748: Kids Online Safety Act
- 119-s-5283: Momnibus Act

## Sources
- [119-s-5297 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/5297)

## Related
- [119-s-4949: Water Resources Development Act of 2026](https://policyrisk.com/legislation/119-s-4949)
- [119-s-1541: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-s-1541)
- [119-s-2838: Protecting Our Democracy Act](https://policyrisk.com/legislation/119-s-2838)
- [119-s-2819: Head Start for America's Children Act](https://policyrisk.com/legislation/119-s-2819)
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-5283: Momnibus Act](https://policyrisk.com/legislation/119-s-5283)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-5297 (as of 2026-08-21).
